503 related articles for article (PubMed ID: 33558427)
1. Stem Cell Therapies in Alzheimer's Disease: Applications for Disease Modeling.
Si Z; Wang X
J Pharmacol Exp Ther; 2021 May; 377(2):207-217. PubMed ID: 33558427
[TBL] [Abstract][Full Text] [Related]
2. Stem-cell challenges in the treatment of Alzheimer's disease: a long way from bench to bedside.
Fan X; Sun D; Tang X; Cai Y; Yin ZQ; Xu H
Med Res Rev; 2014 Sep; 34(5):957-78. PubMed ID: 24500883
[TBL] [Abstract][Full Text] [Related]
3. Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases.
Tcw J
Neurosci Lett; 2019 Apr; 699():31-40. PubMed ID: 30685408
[TBL] [Abstract][Full Text] [Related]
4. Stem Cell Therapy for Alzheimer's Disease.
Han F; Bi J; Qiao L; Arancio O
Adv Exp Med Biol; 2020; 1266():39-55. PubMed ID: 33105494
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.
Yang J; Li S; He XB; Cheng C; Le W
Mol Neurodegener; 2016 May; 11(1):39. PubMed ID: 27184028
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
7. Induced Pluripotent Stem Cell-Derived Neural Precursors Improve Memory, Synaptic and Pathological Abnormalities in a Mouse Model of Alzheimer's Disease.
Armijo E; Edwards G; Flores A; Vera J; Shahnawaz M; Moda F; Gonzalez C; Sanhueza M; Soto C
Cells; 2021 Jul; 10(7):. PubMed ID: 34359972
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
Pinheiro L; Faustino C
Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
[TBL] [Abstract][Full Text] [Related]
9. Stem Cell Therapies for Neurodegenerative Diseases.
Sugaya K; Vaidya M
Adv Exp Med Biol; 2018; 1056():61-84. PubMed ID: 29754175
[TBL] [Abstract][Full Text] [Related]
10. Adult neurogenesis, neural stem cells and Alzheimer's disease: developments, limitations, problems and promises.
Taupin P
Curr Alzheimer Res; 2009 Dec; 6(6):461-70. PubMed ID: 19747153
[TBL] [Abstract][Full Text] [Related]
11. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss.
Ager RR; Davis JL; Agazaryan A; Benavente F; Poon WW; LaFerla FM; Blurton-Jones M
Hippocampus; 2015 Jul; 25(7):813-26. PubMed ID: 25530343
[TBL] [Abstract][Full Text] [Related]
12. Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.
Forest KH; Nichols RA
Trends Mol Med; 2019 Aug; 25(8):685-695. PubMed ID: 31248781
[TBL] [Abstract][Full Text] [Related]
13. Stem cell therapy for Alzheimer's disease.
Abdel-Salam OM
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):459-85. PubMed ID: 21495961
[TBL] [Abstract][Full Text] [Related]
14. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
Machairaki V
Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
[TBL] [Abstract][Full Text] [Related]
15. 3D culture models of Alzheimer's disease: a road map to a "cure-in-a-dish".
Choi SH; Kim YH; Quinti L; Tanzi RE; Kim DY
Mol Neurodegener; 2016 Dec; 11(1):75. PubMed ID: 27938410
[TBL] [Abstract][Full Text] [Related]
16. Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?
Doig AJ; Del Castillo-Frias MP; Berthoumieu O; Tarus B; Nasica-Labouze J; Sterpone F; Nguyen PH; Hooper NM; Faller P; Derreumaux P
ACS Chem Neurosci; 2017 Jul; 8(7):1435-1437. PubMed ID: 28586203
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
18. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.
Marei HE; Khan MUA; Hasan A
Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell-derived extracellular vesicles: a glimmer of hope in treating Alzheimer's disease.
Liew LC; Katsuda T; Gailhouste L; Nakagama H; Ochiya T
Int Immunol; 2017 Jan; 29(1):11-19. PubMed ID: 28184439
[TBL] [Abstract][Full Text] [Related]
20. Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease.
Garcia-Leon JA; Caceres-Palomo L; Sanchez-Mejias E; Mejias-Ortega M; Nuñez-Diaz C; Fernandez-Valenzuela JJ; Sanchez-Varo R; Davila JC; Vitorica J; Gutierrez A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
